Older public exchange base fills 13.6% more prescriptions than those on commercial plans Test that identifies Strep A within eight minutes cleared by FDA Teva’s ProAir RespiClick granted FDA approval Dr. Reddy's Laboratories acquires UCB portfolio RA treatments to reach $9.3 billion in U.S. by 2020 AstraZeneca launches Movantik Amneal to acquire Actavis Australia’s generics business Teva to strengthen CNS portfolio with Auspex acquisition At the scene of NACDS RxIMPACT Day FDA revisits label changes with public meeting First Previous 137 138 139 140 141 Next Last
